Cargando…
Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
Mesenchymal stem cells (MSCs) are promising source of cell‐based regenerative therapy. In consideration of the risk of allosensitization, autologous MSC‐based therapy is preferred over allogenic transplantation in patients with chronic kidney disease (CKD). However, it remains uncertain whether adeq...
Autores principales: | Kim, Hyoungnae, Yu, Mi Ra, Lee, Haekyung, Kwon, Soon Hyo, Jeon, Jin Seok, Han, Dong Cheol, Noh, Hyunjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884040/ https://www.ncbi.nlm.nih.gov/pubmed/33524231 http://dx.doi.org/10.1111/acel.13317 |
Ejemplares similares
-
Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
por: Lee, Haekyung, et al.
Publicado: (2022) -
Sirt1–hypoxia‐inducible factor‐1α interaction is a key mediator of tubulointerstitial damage in the aged kidney
por: Ryu, Dong Ryeol, et al.
Publicado: (2019) -
microRNA in Extracellular Vesicles Released by Damaged Podocytes Promote Apoptosis of Renal Tubular Epithelial Cells
por: Jeon, Jin Seok, et al.
Publicado: (2020) -
Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
por: Kim, Min-Ho, et al.
Publicado: (2021) -
Impaired fasting glucose and development of chronic kidney disease in non-diabetic population: a Mendelian randomization study
por: Kim, Hyoungnae, et al.
Publicado: (2020)